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Extracellular vesicles are released by all cell types including stem cells. Stem cell-released
extracellular vesicles have therapeutic effects similar to those of their parent cells
and have regenerative effects in tissues. They also have an immunomodulating effect
when down-regulating some proinflammatory factors, without exerting effects on cell
proliferation, modulating angiogenesis or altering cellular functions in recipient cells.
Modern veterinary research explores vesicles and creates or advances methods of using
them in regenerative and reproductive medicine, applications of these technologies are
under development.
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INTRODUCTION
Extracellular vesicles are nano-sized cell membrane particles released by different cells and isolated
from most biological fluids. Vesicles play a central role in intercellular communications as they
contain proteins, various RNAs, DNAs, lipids, and other biomolecules which are targeted for
intercellular delivery and exchange (paracrine signaling) both at system and local tissue levels.
Extracellular vesicles also regulate normal physiological processes in organisms (1). They are a
heterogeneous group of cell-derivedmembranous structures comprised of exosomes, microvesicles
(MV) and apoptotic bodies which are released under physiological conditions as well as in cell
activation, aging and apoptosis (Table 1). According to the literature their release can also maintain
cell integrity by eliminating harmful substances from a cell (2). Moreover, Badierah et al. noticed
that extracellular vesicles can spread viral infection in the body overcoming the immune system (3).
Stem cells (SCs) are known to be capable of producing extracellular vesicles. SC-released
extracellular vesicles with a paracrine mechanism exert a therapeutic effect similar to that of their
parent cells (4). At present, the research of properties and possible ways to use these SC derivatives
is a promising trend in biology and medicine (5) as well as the use of artificial MV (6). However,
this is understudied in veterinary medicine (7).
IN VITRO STUDY OF BIOLOGICAL PROPERTIES OF ANIMAL
EXTRACELLULAR VESICLES
According to the literature, extracellular vesicles have presently been derived and characterized
from porcine, canine and equine mesenchymal stem cells (MSCs) as well as from equine
amnion mesenchymal stromal cells (aMSCs). The Mesenchymal and Stem Cells Committee of the
International Society for Cellular Therapy stated minimal criteria for defining MSCs. They must be
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TABLE 1 | Classification of extracellular vesicles.
Extracellular
vesicles






1,000–5,000 Cell defragmentation into parts, surrounded by a
cellular membrane
Genome DNA, whole organelles, rRNA Phagocytosed by cells, a
transport function is possible
Microvesicles 100–1,000 Cellular membrane protrusion and pinching into
extracellular space
Parent cell markers, enzymes,
transcription factors, molecules of mRNA
Mediate a distant interaction
between cells
Exosomes 30–150 Budded into a cell cavity, forming an ednosome
which fuses with a surface cell membrane and an
aggregation of exosomes is extruded/forced out
A particular set of membrane and cytosol
proteins, mRNA, siRNA
Mediate a distant interaction
between cells
DNA, deoxyribonucleic acid; RNA, ribonucleic acid; mRNA, matrix ribonucleic acid; siRNA, small interfering ribonucleic acid; rRNA, ribosomal ribonucleic acid.
plastic-adherent, have a specific surface membrane markers
profile and be able to differentiate into osteoblasts, adipocytes and
chondrocytes in vitro (Figure 1).
Immunophenotyping is one of themost relevant tests to define
cells derived as MSCs. For example, they must express markers
such as CD105, CD73, CD29, CD44, CD106, CD166, CD90, but
lack the expression of CD45, CD34, CD14, CD11b, CD79a, CD19
(8, 9).
Two main sources of MSCs such as bone marrow (BM)
and adipose tissue (AT) are usually used for the treatment of
dogs in regenerative veterinary medicine. Investigators note that
despite a similar immunophenotype manifested by BM- and AT-
MSCs, AT-MSCs act on cell proliferation more actively than BM-
MSCs do while the latter have a significantly higher secretory
production of some soluble factors, as well as exosomes under
standard culturing conditions. Thus, it is recommended that
biological differences are taken into consideration when selecting
a source of MSCs for cell transplantation (10).
Studies demonstrated that equine AT-MSCs were able to
produce extracellular vesicles. Horse MSC-derived membrane
vesicles could have an effect during a key stage in tissue
regeneration, angiogenesis (11, 12). The further study of
equine AT-MSC derivatives showed that an extracellular vesicle
membrane contained CD90 and flotillin-1, which are considered
as markers of MV and exosomes, respectively (13); therefore,
equine AT-MSCs express extracellular vesicles of two types. In
general, membrane vesicles of equine MSCs could potentially be
used as a therapeutic tool in regenerative veterinary medicine.
Extracellular MVs of aMSCs in an in vitro model of
horse tendinitis have an immunomodulating effect when down-
regulating some proinflammatory factors without any effect
on cell proliferation (14). It was shown that these effects
were due to microvesicle miRNAs. For example, miRNA-150
reduces the secretion of inflammatory cytokines (15). Protective
properties identified in extracellular MVs would facilitate
development of the principle of using these cell derivatives
in a veterinary practice for the treatment of tendinitis for
example, as tendon and ligament injuries in sporting horses.
At present regeneration of damaged tissue is challenging.
This is due to the limited abilities of tendon and ligament
tissue regeneration primarily due to scarring as a result of a
relatively low number of resident cells as compared to the
matrix (16).
Pig AT-MSC-derived extracellular vesicles contain mRNAs
of transcription factors and genes involved in angiogenesis
and adipogenesis, as well as those of the Golgi complex. At
the same time, mitochondrial, calcium signal, and cytoskeletal
genes are selectively removed from them. The analysis of
pig AT-MSC-derived extracellular vesicles demonstrates that
their miRNAs regulate functions of transcription factors and
genes which are involved in some cellular processes including
angiogenesis, cellular transport, apoptosis, and proteolysis. These
cell derivatives transport regulatory information to modulate
angiogenesis, adipogenesis, and other cellular functions in
recipient cells. The results described may assist in developing
regenerative strategies for the treatment of various diseases in
animals with the use of extracellular vesicles (17).
POTENTIAL USE OF EXTRACELLULAR
VESICLES IN VETERINARY MEDICINE
Sabry et al. conducted an experimental study of dog BM-MSC-
derived microvesicle effects on the regeneration of an induced
chondral defect. Chondral defects were created surgically in
canine femoral condyles. The investigators isolated autologous
MSCs and obtained natural MVs when culturing in vitro, which
were infra-articularly injected. A saline solution was injected into
another injured joint as a negative control. MVs obtained in
culturing dog BM-MSCs exerted an evident proliferative effect
on dog chondrocytes in an in vitro experiment. In in vivo studies
where MVs were injected into dog joints, the cartilage evidently
regenerated and the chondral histomorphology restored in the
experimental group at the end of a 6-month follow-up period as
compared to control joints in which the condition got worse with
the time and the defect was filled with fibrous tissue forming a
fibrous cartilage. Researchers concluded that autologous dog BM-
MSC derivedMVs were effective for the restoration of the injured
cartilage functions and morphology. This approach can be used
as the concept of cell-free therapy in regenerative and veterinary
medicine (18).
Natural MVs obtained when culturing dog BM-MSCs were
also effective for regeneration of full-thickness skin following wo
unds in dogs. The histological findings in the experimental group
showed that the use of MVs stimulated skin wound healing, even
on day 3 after their use, and collagen synthesis. This not only
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FIGURE 1 | Directed differentiation of adipose - derived stem cells. Adipogenic differentiation: MSCs nuclei are stained with Dapi (blue), adipose tissue inclusions
within cells are dyed with Nile Red (yellow). Osteogenic differentiation: Von Kossa staining showed calcium containing areas as brown in color. Chondrogenic
differentiation: acid mucopolysaccharides of the extracellular matrix formed within the differentiation of MSCs into chondrocytes are stained with Alcian blue.
promoted the formation of new blood vessels but also accelerated
vascular development andmaturation. Therefore, the use of MVs
for the treatment of skin wounds is promising in relation to
the development of a novel cell-free therapeutic approach which
might overcome risks related to SC transplantation (19).
USE OF EXTRACELLULAR VESICLES IN
VETERINARY REPRODUCTIVE
CONDITIONS
The conservation of genetic material from animals with a high
breeding value or those endangered as a result of any disease
or a disaster is one of the current issues in veterinary science
and medicine. This is achieved by freezing mammal semen
and oocytes.
The use of cryoconserved sperm in dogs reduces
problems accompanying natural breeding, transportation
and international trading. However, the process of freezing
can have a particularly adverse impact on the morphology of
spermatozoon caused by thermal, mechanical, chemical, osmotic,
and oxidative damage (20). These effects result in the reduction
in spermatozoon motility, DNA damage. Overall these result in
a reduction in spermatozoon fertilizing capacity. The restoration
of spermatozoon impaired by freezing is extremely important
for the improvement of its viability and fertility. Researchers
studied the effects of canine AT-MSC-derived exosomes
on dog spermatozoon structure and functions following
cryoconservation. Having been thawed the spermatozoon
previously treated with exosomes had better motility, a higher
percentage of living sperm, and better membrane and acrosome
integrity as compared to the controls. Moreover, the expression
of genes associated with plasmalemma and chromatin material
reparation was statistically higher in exosome-treated sperm
than in the controls; however, the expression of a mitochondrial
modulator gene of reactive oxygen species 1 was significantly
higher in the controls (20).
There are data available on the effects of MVs secreted
by multicellular spheroids of cells isolated from dog oviducts
have on (dog) oocyte maturation. Results obtained suggest that
MVs in specific concentrations had a positive effect on the
oocyte maturation rate. They also showed effects on target
cells, even without a direct contact between cells, that is
exampled by oocytes and the secretome produced by dog
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oviduct cells. The investigators considered that the maintenance
of oocyte viability and maturation was affected by specific
miRNAs in substances dissolved in MVs rather than these
substances alone. This study clarifies a mechanism of possible
paracrine effects the oviduct has on oocytes and is significant
for the development of in vitro biotechnologies in veterinary
medicine (21).
Ferraz et al. found that the majority of extracellular vesicles
which are present in the domestic cat oviduct are exosomes.
Experiments in vitro demonstrated that incubation of cat
spermatozoon with cat oviduct exosomes maintained a
higher percentage of motile spermatozoon as compared to
control intact ones, and persisted for a 24-h. Therefore, a
spermatozoon receives energy from molecules which are
present in a spermatic fluid and in female reproductive organs.
Increased motility might have been due to the transfer of
proteins, related to energy metabolism from exosomes into
spermatozoa. In addition, there was an increased fertilizing
ability that seems to be caused by proteins, related to
recognition and binding of sperm cells with oocytes. In
vitro studies are of great importance for captive breeding of
endangered cats (and many other species) as a result of them
losing natural habitats. Adjuvant reproductive technologies
including artificial fecundation and in vitro fertilization
used to maintain genetic diversity and to prevent in-bred
depression (22).
Equine aMSC MVs in a model of horse endometriosis
exert a prominent anti-inflammatory effect. It is supposed that
miRNAs in aMSC MVs stimulate cell proliferation, reduce the
expression of pro-inflammatory genes and decrease secretion of
pro-inflammatory cytokines in vitro. The results obtained are of
practical value as endometritis is the main cause of decreased
fertility, conception rate, prolongs periods from calving to
conception, and results in culling and ultimately in economic and
food production losses too, in mares and cattle which occurs in
artificial fecundation (15).
At present the use of extracellular vesicles as a potential
cell-free therapy in veterinary medicine is promising for
the treatment of different animal diseases and is a novel
therapeutic strategy. However, a limited yield and labor-
consuming procedures to isolate natural extracellular vesicles
make large-scale pharmaceutical production challenging and
presently restricts their wider use in pre-clinical and clinical
trials. There are modern developments which can support
these aims, such as release of extracellular vesicles which is
stimulated with cytochalazine B. The use of cytochalasin B-
induced membrane vesicles as vectors for the delivery of
nanoparticles and drugs, when reducing in vivo toxicity of
chemotherapy in medical studies has been reported (23, 24).
However, these studies have not been conducted in veterinary
fields. Nevertheless, a similar technique to obtain extracellular
vesicles is applicable in veterinary medicine and makes it possible
to develop new methods for the regeneration of damaged tissue
and the maintenance of animal reproductive health.
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